Previous studies have clearly shown that patients with BRAF mutant colorectal cancer (CRC) receiving adjuvant chemotherapy following resection have a worse outcome compared to their BRAF wild type counterparts [1, 2]. Here, BRAF is linked to colorectal cancer.